CD5 and B-cell chronic lymphocytic leukemia: Based on a study on 423 CLL patients, Friedman et al. propose that the mean fluorescence intensity of the CD5 antigen on CLL cells may correlate with the clinical course of the disease: high mean fluorescence intensity rate correlated with longer progression-free survival (PFS) [44].